Ginkgo Investor Conference Presentation Deck
We partner to address challenges from Discovery through Manufacturing
Over 100 cumulative programs with partners across industries
THERAPEUTICS & VACCINES
Antibody
Discovery
High-throughput
screening of COVID-19
antibodies from patient
RNA-Seq data
OTOTIENT
NON-THERAPEUTICS
Bio-agriculture
Engineering
crop-colonizing
microbes for
sustainable
agriculture
JOYN
BIO
B
BAYER
E
R
Antibiotics
Discovery
Genome mining for
identification of novel
classes of antibiotics
Roche
Animal Protein
Discovery and design
of new approaches to
developing
plant-based foods
and food ingredients
motif
FOODWORKS
Enzyme
Discovery
Enzyme discovery
and engineering for
reducing
immunogenicity for
therapeutics
Selecta..
Biosciences
Plant Extracts
Engineering cells to
produce cultured plant
ingredients for flavor,
fragrance and
cannabinoid industries
ROBERTET
CRONOS
GROUP
Givaudan Antheia
Living
Therapeutics
Engineering metabolic
pathways in microbes
towards therapeutic
candidates for
metabolic disorders
synlogic
Oligosaccharides
Optimization and scaling
of the production of
human milk
oligosaccharides for a
suite of products
Glycosyn
Gene Therapy
Platform
Optimize recombinant
adeno-associated virus
(AAV)-based vectors
Biogen
Selecta
of Biosciences
Chemicals
Develop more
sustainable
bio-based chemicals
for multiple industries
Sumitomo
Biologics & Reagent
Production
Rapid, multiplexed design of
experiments for reagent and
process development &
optimization
aldevron
saponi@x
Optimvia
Industrial
Create a fast and more
effective way to create
enzymes for the food
industry
KERRY
Enzymes
Cargill
12
Property of Ginkgo Bioworks
J.P. MORGAN HEALTHCARE CONFERENCE 2022View entire presentation